Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01828346
Show Display Options
Rank Status Study
1 Recruiting Birinapant With 5-azacitidine in MDS Subjects Who Are Naïve, Have Relapsed or Are Refractory to 5-azacitidine Therapy
Condition: Myelodysplastic Syndrome
Interventions: Drug: TL32711;   Drug: 5-Azacitidine

Indicates status has not been verified in more than two years